Our mission: The Center for Structural Genomics of Infectious Diseases is a consortium of laboratories using state-of-the-art structural biology methods to determine the 3-D structures of proteins from pathogens in the NIAID Category A-C priority lists and organisms causing emerging and re-emerging infectious diseases. We do this as a free service to the scientific community! Members of the scientific community are encouraged to submit their targets of interest to CSGID by using our online form: Submit/check your proposal now!
For more detailed information about our mission, please refer to the CSGID brochure (pdf) and the Overview.

Latest news:
A study by CSGID researchers and collaborators on Ebola virus replication has been featured as one of the outstanding NIAID research advances of 2015!

Targets: 8352
Targets requested by the community: 2694
Community Interest targets: 143
Targets with structures: 560
Structures: 848 (X-ray: 842, NMR: 6)
Structures complexed with ligands: 330
Solved proteins requested by community: 199 (324 structures)
Solved Community Interest targets: 47 (95 structures)
Publications: 119 (64 structural, 55 methodological/other)
Citations: 1567 (558 for structural, 1009 for methodological/other)
Community Collaborators:
.
CSGID is soliciting requests from the scientific community for protein structure determination: submission form


Target IDP01169     Latest NIAID structure of the month

Title: AtxA protein, a virulence regulator from Bacillus anthracis

Authors: J.Osipiuk,L.B.Horton,T.M.Koehler,W.F.Anderson,A.Joachimiak,Center For Structural Genomics Of Infectious Diseases (Csgid)

 
Target IDP91955    Latest community request

Title: Crystal structure of iron uptake ABC transporter substrate-binding protein PiaA from Streptococcus pneumoniae Canada MDR_19A bound to hydroxymate siderophore ferrioxamine E and iron(III)

Authors: Stogios Pj, Wawrzak Z, Kudritska M, Yim V, Savchenko A, Anderson Wf, Center For Structural Genomics Of Infectious Diseases (Csgid)

 

This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contracts No. HHSN272200700058C and HHSN272201200026C.